Related Experiment Video
Updated: Jan 24, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Evaluation of a Library of FDA-Approved Drugs for Their Ability To Potentiate Antibiotics against Multidrug-Resistant
Charlotte K Hind1, Christopher G Dowson2, J Mark Sutton3
1Research and Development Institute, National Infection Service, Public Health England, Porton Down, United Kingdom charlotte.hind@phe.gov.uk.
Abstract:
The Prestwick library was screened for antibacterial activity or "antibiotic resistance breaker" (ARB) potential against four species of Gram-negative pathogens. Discounting known antibacterials, the screen identified very few ARB hits, which were strain/drug specific. These ARB hits included antimetabolites (zidovudine, floxuridine, didanosine, and gemcitabine), anthracyclines (daunorubicin, mitoxantrone, and epirubicin), and psychoactive drugs (gabapentin, fluspirilene, and oxethazaine). These findings suggest that there are few approved drugs that could be directly repositioned as adjunct antibacterials, and these will need robust testing to validate efficacy.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Development of Antibiotic Resistance
Gram-negative Bacterial Protein Secretion Systems
Antibiotic Selection
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Negative Regulator Molecules

